Biotech/Pharma stocks News; BioSante Pharmaceuticals Reports Positive LibiGel® Safety Data Review in Phase III Program
Posted on October 11, 2011 at 15:24 PM EDT
LINCOLNSHIRE, Ill. - October 11, 2011 (Investorideas.com newswire) - BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX), announced today that the independent Data Monitoring Committee (DMC) has completed the seventh unblinded review of the LibiGel Phase III...